Abstract:Oral bioavailability is an essential parameter in drug screening cascades and a good indicator of the capability of the delivery of a given compound to the systemic circulation by oral administration. In the present work, we report a database of oral bioavailability of 1014 molecules determined in humans. A systematic examination of the relationships between various physicochemical properties and oral bioavailability were carried out to investigate the influence of these properties on oral bioavailability. A number of property-based rules for bioavailability classification were generated and evaluated. We found that no rule was an effective predictor for oral bioavailability because these simple rules cannot characterize the influence of important metabolic processes on bioavailability. Finally, the genetic function approximation (GFA) technique was employed to construct the multiple linear regression models for oral bioavailability using structural fingerprints as the basic parameters, together with several important molecular properties. The best model is able to predict human oral bioavailability with an r of 0.79, a q of 0.72, and a RMSE (root-mean-square error) of 22.30% of the compounds from the training set. The analysis of the descriptors chosen by GFA shows that the important structural fingerprints are primarily related to important intestinal absorption and well-known metabolic processes. The predictive power of the models was further evaluated using a separate test set of 80 compounds, and the consensus model can predict the oral bioavailability with r(test) = 0.71 and RMSE = 23.55% for the tested compounds. Since the necessary molecular properties and structural fingerprints can be calculated easily and quickly, the models we proposed here may help speed up the process of finding or designing compounds with improved oral bioavailability.

Evaluating the Use of Graph Neural Networks and Transfer Learning for Oral Bioavailability Prediction

Leveraging Graph Neural Networks for Enhanced Prediction of Molecular Solubility via Transfer Learning

Could graph neural networks learn better molecular representation for drug discovery? A comparison study of descriptor-based and graph-based models

Predicting Solubility with Residual Gated Graph Neural Network

Benchmarking Accuracy and Generalizability of Four Graph Neural Networks Using Large In Vitro ADME Datasets from Different Chemical Spaces

A New Fingerprint and Graph Hybrid Neural Network for Predicting Molecular Properties

Predicting Drug Solubility Using Different Machine Learning Methods -- Linear Regression Model with Extracted Chemical Features vs Graph Convolutional Neural Network

An Adaptive Graph Learning Method for Automated Molecular Interactions and Properties Predictions

Improving chemical reaction yield prediction using pre-trained graph neural networks

Predicting Drug Effects from High-Dimensional, Asymmetric Drug Datasets by Using Graph Neural Networks: A Comprehensive Analysis of Multitarget Drug Effect Prediction

ADME evaluation in drug discovery. 9. Prediction of oral bioavailability in humans based on molecular properties and structural fingerprints.

A survey of drug-target interaction and affinity prediction methods via graph neural networks

Drug Solubility Prediction: A Comparative Analysis of GNN, MLP, and Traditional Machine Learning Algorithms

Transfer Learning Graph Representations of Molecules for pKa, 13C-NMR, and Solubility

A Novel Chemometric Method for the Prediction of Human Oral Bioavailability

GGAS2SN: Gated Graph and SmilesToSeq Network for Solubility Prediction

Graph Neural Networks for COVID-19 Drug Discovery

Accurate Predictions of Molecular Properties of Proteins via Graph Neural Networks and Transfer Learning

Accurate, reliable and interpretable solubility prediction of druglike molecules with attention pooling and Bayesian learning

Integrated Transfer Learning and Multitask Learning Strategies to Construct Graph Neural Network Models for Predicting Bioaccumulation Parameters of Chemicals